Table 6.6d

Immunosuppression Use for Maintenance by Regimen

Prior to Discharge, 1999 to 2008

Recipients with Pancreas Transplant Alone (PTA) Transplants

	Transplant Year
	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008
Functioning Graft at Discharge	127	113	151	169	141	170	181	152	187	202
With Immunosuppression Info	126	113	150	169	139	169	181	151	185	201
Tac	25.4%	16.8%	19.3%	22.5%	17.3%	13.0%	17.7%	10.6%	6.5%	6.5%
--- + MMF/MPA	0.0%	0.0%	0.0%	0.6%	11.5%	19.5%	2.8%	0.0%	0.0%	0.0%
CyA + MMF/MPA	0.0%	0.0%	0.7%	1.2%	0.7%	0.6%	0.0%	0.7%	1.1%	0.0%
Tac + MMF/MPA	2.4%	0.9%	0.0%	1.2%	5.0%	8.3%	17.1%	18.5%	20.5%	29.4%
Tac + OtherAntimet	0.0%	0.0%	0.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
--- + Siro/Evero	0.0%	0.0%	0.0%	0.6%	0.7%	0.6%	0.0%	0.0%	0.0%	0.0%
CyA + Siro/Evero	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.7%	0.0%	0.0%
Tac + Siro/Evero	0.8%	1.8%	1.3%	1.8%	10.8%	7.1%	6.6%	4.0%	1.6%	1.0%
--- + MMF/MPA + Siro/Evero	0.0%	0.0%	0.0%	0.0%	0.7%	0.0%	0.6%	0.0%	0.0%	0.0%
CyA + MMF/MPA + Siro/Evero	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.5%	0.0%
Tac + MMF/MPA + Siro/Evero	0.0%	0.0%	0.7%	3.0%	0.0%	1.2%	3.3%	12.6%	11.9%	6.5%
--- + Steroids	0.0%	0.9%	0.0%	0.6%	0.7%	1.8%	3.3%	0.7%	1.6%	1.0%
CyA + Steroids	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.5%
Tac + Steroids	8.7%	4.4%	12.0%	7.1%	7.9%	15.4%	11.0%	21.9%	28.1%	25.4%
--- + MMF/MPA + Steroids	2.4%	0.0%	0.0%	0.0%	0.7%	0.6%	0.0%	0.0%	1.1%	1.0%
CyA + MMF/MPA + Steroids	2.4%	3.5%	3.3%	1.2%	0.7%	0.0%	0.0%	0.7%	0.5%	0.0%
Tac + MMF/MPA + Steroids	57.1%	61.9%	54.0%	49.1%	38.1%	28.4%	33.1%	20.5%	22.2%	23.9%
Tac + OtherAntimet + Steroids	0.0%	1.8%	0.7%	0.6%	0.0%	1.2%	0.0%	0.0%	1.1%	0.0%
--- + Siro/Evero + Steroids	0.0%	0.0%	0.7%	0.0%	0.7%	0.6%	0.6%	0.7%	0.0%	0.0%
CyA + Siro/Evero + Steroids	0.0%	0.9%	0.0%	0.6%	0.7%	0.6%	0.0%	0.0%	0.0%	0.0%
Tac + Siro/Evero + Steroids	0.8%	4.4%	4.7%	7.1%	1.4%	0.6%	3.3%	6.0%	2.7%	2.5%
Other Regimen	0.0%	2.7%	2.0%	3.0%	2.2%	0.6%	0.6%	2.6%	0.5%	2.5%

Source: OPTN/SRTR Data as of May 4, 2009.

Percentages in each column sum to 100 percent.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.